drugset
drugset / Trial / NCT04140968

Progesterone and Resting Energy Expenditure

NCT04140968 ↗

Phase 4 Terminated 2 enrolled Insel Gruppe AG, University Hospital Bern
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the effect of micronized progesterone substitution in the luteal phase on resting energy expenditure in women during menopausal transition.

Timeline

Start
2019-11-01
Primary completion
2021-05-27
Completion
2021-05-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 300 mg Oral

Indications

No indication recorded.